99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib

China 99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib, Find details about China Bortezomib, Bortezomib Powder from 99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib

Basic Info.

Model NO.

Condavo-Bortezomib

Name

Bortezomib

Product Name

Bortezomib Powder

Appearance

Yellow Powder

Color

Yellow Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

179324-69-7

C19h25bn4o4

384.23700

Density

1.214

Melting Point

122-124c

Boiling Point

684.30c

Refractive Index

1.564

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Bortezomib

Name

Bortezomib

Product Name

Bortezomib Powder

Appearance

Yellow Powder

Color

Yellow Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

179324-69-7

C19h25bn4o4

384.23700

Density

1.214

Melting Point

122-124c

Boiling Point

684.30c

Refractive Index

1.564

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

99% purity powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib

99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib

Product Name	Bortezomib
CAS	179324-69-7
Appearance	Yellow crystalline powder
MF	C19H25BN4O4
MW	384.23700
Purity	99%
Shelf Life	2 Years

Bortezomib is an injection. Bortezomib is a reversible inhibitor of the chymase-like activity of 26S protease in mammalian cells. In vitro tests demonstrated that bortezomib is cytotoxic to many types of cancer cells. Preclinical tumor models In vivo testing demonstrates that bortezomib delays tumor growth, including multiple myeloma. This product is used in the treatment of patients with multiple myeloma, the effectiveness is based on its efficiency.

99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib

1.Multiple myeloma
This product can be used in combination with melp halan and prednione (MP regimen) for the treatment of multiple myeloma patients who have not previously been treated and are not suitable for high-dose chemotherapy and myelosuppression; Or more than one treatment of relapsed patients with multiple myeloma.

2.Mantle cell lymphoma
This product can be used for the treatment of patients with relapsed or refractory mantle cell lymphoma. This patient received at least one treatment before using this product.

99% Purity Powder Antineoplastic Bortezomi Chemical Bortezomib Powder Bortezomib Bortezomib, a modified dipeptidyl boronic acid, is a therapeutic proteasome inhibitors used for the treatment of cancers. It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting the mammalian 26S proteasome, which is important in regulating the intracellular concentration of specific proteins to maintain homeostasis within cells. The disruption of 26S proteasome function disrupts normal cellular homeostasis, leading to cytotoxic effect on various kinds of cancer cells.